3
16
Y. Bramoullé et al. / Tetrahedron Letters 51 (2010) 313–316
1
1
5. Berridge, M.; Comar, D.; Crouzel, C. Int. J. Appl. Radiat. Isot. 1983, 34, 1657.
6. Ouellet, R.; Rousseau, J.; Brasseur, N.; van Lier, J. E.; Diksic, M.; Westera, G. J.
Med. Chem. 1984, 27, 509.
7. Diksic, M. Int. J. Appl. Radiat. Isot. 1984, 35, 1035.
8. Conway, T.; Diksic, M. J. Nucl. Med. 1988, 29, 1957.
9. Conway, T.; Diksic, M. Appl. Radiat. Isot. 1991, 42, 441.
0. Ali, H.; Rousseau, J.; Diksic, M.; van Lier, J. E. Nucl. Med. Biol. 1992, 19, 175.
1. Bernard, S.; Fuseau, C.; Schmid, L.; Milcent, R.; Crouzel, C. Eur. J. Nucl. Med.
42. Nishijima, K. I.; Kuge, Y.; Seki, K.; Ohkura, K.; Motoki, N.; Nagatsu, K.; Tanaka,
A.; Tsukamoto, E.; Tamaki, N. Nucl. Med. Biol. 2002, 29, 345.
[
C]methane ([11C]CH
4
) was
11
43. Radioisotope production: No-carrier-added
produced on an IBA Cyclone-18/9 cyclotron (18 MeV proton beam, IBA,
1
1
1
2
2
14
11
Louvain-la-Neuve, Belgium) via the
irradiation of a target consisting of an ultrapure mixture of dinitrogen and
dihydrogen (N /H , 95/5 (v:v), Air Liquide). The dedicated aluminium target
[ N(p,a) C] nuclear reaction by
2
2
holder (IBA, Louvain-la-Neuve, Belgium) contains the gas mixture at 20 bar
(beam off) in a volume of 50 mL. Typical production for the present work:
1
996, 23, 150.
11
2
2
2
2
2
2
2
2
2. Roeda, D.; Tavitian, B.; Coulon, C.; David, F.; Dollé, F.; Fuseau, C.; Jobert, A.;
ꢁ1.85 GBq of
4
[ C]CH at the end of bombardment for a 5 lA, 5 min
Crouzel, C. Bioorg. Med. Chem. 1997, 5, 397.
3. Lidström, P.; Bonasera, T. A.; Marquez, M. M.; Nilsson, S.; Bergström, M.;
Långström, B. Steroids 1998, 63, 228.
4. Steel, C. J.; Brady, F.; Luthra, S. K.; Brown, G.; Khan, I.; Poole, K. G.; Sergis, A.;
Jones, T.; Price, P. M. Appl. Radiat. Isot. 1999, 51, 377.
5. Amokhtari, M.; Andersen, K.; Ibazizène, M.; Gourand, F.; Dauphin, F.; Barré, L. J.
Label. Compd. Radiopharm. 1999, 42, 437.
6. Dollé, F.; Valette, H.; Hinnen, F.; Vaufrey, F.; Demphel, S.; Coulon, C.; Ottaviani,
M.; Bottlaender, M.; Crouzel, C. J. Label. Compd. Radiopharm. 2001, 44, 785.
7. Brown, G. D.; Luthra, S. K.; Brock, C. S.; Stevens, M. F. G.; Price, P. M.; Brady, F. J.
Med. Chem. 2002, 45, 5448.
8. Roger, G.; Lagnel, B.; Besret, L.; Bramoullé, Y.; Coulon, C.; Ottaviani, M.; Kassiou,
M.; Bottlaender, M.; Valette, H.; Dollé, F. Bioorg. Med. Chem. 2003, 11, 5401.
9. Roger, G.; Dollé, F.; de Bruin, B.; Liu, X.; Besret, L.; Bramoullé, Y.; Coulon, C.;
Ottaviani, M.; Bottlaender, M.; Valette, H.; Kassiou, M. Bioorg. Med. Chem. 2004,
irradiation.
44. To avoid1 [13N]ammonia one could make [11C]methane from [11C]carbon
4
11
45–47
2 2
dioxide ( N(p,a) C, N /O target) and dihydrogen catalyzed by nickel.
11
This dispenses from [ C]methane dedicated cyclotron targetry and the trap T
0
11
as no ammonia is produced. Also, [ C]carbon dioxide usually can be produced
in larger quantities than [11C]methane. On the other hand it introduces an
additional radiochemical transformation requiring an additional oven and
11
hydrogen gas manipulation.
specific radioactivity than [ C]carbon dioxide.
[
C]Methane often has
a somewhat higher
11
45. Dence, C. S.; Herrero, P.; Schwarz, S. W.; Mach, R. H.; Gropler, R. J.; Welch, M. J.
Methods Enzymol. 2004, 385, 286.
46. Larsen, P.; Ulin, J.; Dahlstrøm, K.; Jensen, M. Appl. Radiat. Isot. 1997, 48, 153.
47. Link, J. M.; Krohn, K. A.; Clark, J. C. Nucl. Med. Biol. 1997, 24, 93.
1
1
48. System preparation before [ C]phosgene synthesis: Phosphorus pentoxide (1.5 g)
and antimony (4 g of a 60/40 (w/w) mixture of antimony powder and 1 mm
1
2, 3229.
glass beads) fillings are renewed before each synthesis. The Porapak-Q in T
and T can be reused an indefinite number of times. The system is thoroughly
flushed with helium while the ovens are heating the quartz tubes. The helium
flow is finally stopped and the helium in vessel M is replaced by chlorine gas
(99.99%, Air Liquide) by way of a 3 mL syringe. Vessel M is isolated from the
rest of the system by valves as is the system as a whole from the exterior.
1
3
3
3
3
3
3
3
0. Dollé, F.; Martarello, L.; Bramoullé, Y.; Bottlaender, M.; Gee, A. D. J. Label.
Compd. Radiopharm. 2005, 48, 501.
1. Ohkura, K.; Nishijima, K. I.; Sanoki, K.; Kuge, Y.; Tamaki, N.; Seki, K. I.
Tetrahedron Lett. 2006, 47, 5321.
2. Seki, K. I.; Nishijima, K. I.; Kuge, Y.; Tamaki, N.; Wiebe, L. I.; Ohkura, K. A. J.
Pharm. Pharmaceutical Sci. 2007, 10, 212.
3. Takahashi, M.; Seki, K.; Nishijima, K.; Kuge, Y.; Tamaki, N.; Ohkura, K.
Heterocycles 2008, 76, 237.
4. Bramoullé, Y.; Puech, F.; Saba, W.; Valette, H.; Bottlaender, M.; George, P.;
Dollé, F. J. Label. Compd. Radiopharm. 2008, 51, 153.
5. Seki, K.; Nishijima, K.; Sanoki, K.; Kuge, Y.; Takahashi, M.; Akizawa, H.; Tamaki,
N.; Wiebe, L. I.; Ohkura, K. Heterocycles 2009, 77, 1307.
6. Hooker, J. M.; Reibel, A. T.; Hill, S. M.; Schueller, M. J.; Fowler, J. S. Angew. Chem.,
Int. Ed. 2009, 48, 3482.
2
49. Gas chromatography was performed using
a Delsi-Nermag DN 200 MC
0
0
apparatus; column: Hayesep-Q 80/100 mesh (2 m ꢂ 1/8 ); helium (15 mL/
min); catharometer and radioactivity detection. The retention times of the
11
11
4
various radioactive products were as follows: [ C]CO: 0.9 min, [ C]CH :
11 11 11
1.5 min, [ C]CO
[ C]CCl
4
2
: 2.8 min, [ C]CH
: 14.0 min.
50. High performance liquid chromatography (HPLC) was performed using
Waters 510 pump, a Shimadzu SPD10-AVP UV-multi-wavelength spectrometer
2 2 3
Cl : 8.5 min, [ C]CHCl : 10.8 min and
11
a
Ò
and a Geiger–Müller detector; column: semi-preparative Lichrosorb SiO
Merck (250 ꢂ 10 mm; porosity: m); solvents and conditions: isocratic
elution with CH Cl /EtOH/H O/EtNH : 990/9.6/0.2/0.2 (v:v:v:v); flow rate:
2
,
3
3
3
4
4
7. Kihlberg, T.; Karimi, F.; Långström, B. J. Org. Chem. 2002, 67, 3687.
8. Roeda, D.; Crouzel, C.; van Zanten, B. Radiochem. Radioanal. Lett. 1978, 33, 175.
9. Roeda, D.; Westera, G. Int. J. Appl. Radiat. Isot. 1981, 32, 931.
0. Landais, P.; Crouzel, C. Appl. Radiat. Isot. 1987, 38, 297.
1. Link, J. M.; Krohn, A. J. Label. Compd. Radiopharm. 1997, 40, 306.
7 l
2
2
2
2
8.0 mL/min; temperature: rt; absorbance detection at k = 254 nm. Capacity
0
factors: phenyl isocyanate: 6.45, N,N -diphenylurea: 1.73, chloromethanes:
1.00.